Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cysteamine hydrochloride
Cat. No.:
OB0225LY-0317
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Cysteamine hydrochloride is an amino acid derivative with reducing properties commonly used in biochemical and pharmacological studies.
Synonym:
2-Mercaptoethylamine hydrochloride; β-Mercaptoethylamine hydrochloride; Thioethanolamine ydrochloride; 2-Aminoethanethiol hydrochloride; Cysteamine HCl; Bekaptan; 156-57-0
CAS No.:
156-57-0
Formula:
C2H7NS·HCl
Formula Weight:
113.61
Specification
Relative Density:
0.75 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cysteamine hydrochloride can be used to study intracellular redox reactions or play an important role in the study of neuroprotective effects.
Library Information
Targets:
Reactive oxygen species
Pathways:
Metabolism; Apoptosis; Autophagy; Immunology/Inflammation; NF-κB
Plate Number:
AOCL-5
Plate Location:
a10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 528.12 mM
Water Max Solubility:
21 mg/mL; 184.8 mM
Ethanol Max Solubility:
22 mg/mL; 193.6 mM
